
Stonegate Capital Partners Updates Coverage on OS Therapies Inc.: Regulatory Clarity and Key Catalysts Ahead
Stonegate Capital Partners highlights OS Therapies' progress toward late-stage regulatory milestones, including EMA rolling review and TGA endpoint alignment, with dense 2026 catalysts centered on survival data.
Read full story





















